Cited 0 times in
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.